Bridge Point Capital and Beijing Grand Height Announced a Strategic Partnership

Updated: Jul 22, 2021

Bridge Point Capital (BPC), a New York-based private equity firm that specializes in U.S/China cross-border investments today announced that the formation of a strategic partnership with Beijing Grand Height (GDHT Capital), a Chinese technology investment institution belonging to the Zhongguancun Financial Information Technology Alliance (FITA).

Since its establishment, FITA has gathered more than 100 Chinese high-tech enterprises and well-known financial institutions with international scale and rapid development speed. The total output value of enterprises in the alliance is more than one trillion RMB, and it is currently one of the institutions with the most extensive coverage and the most influential leading companies in the technology and financial sector in China.

GDHT Capital, as one of the major investment institutions under FITA, is jointly founded by high-tech enterprises, financial professionals, science & technology experts, and academic scholars to capture investment opportunities brought by state-of-the-art technologies. It has established a national-level ultra-high-definition video industry investment fund, a communications development investment fund, and initiated the establishment of Shanghai Xuanyi Technology Innovation Investment Fund as a GP manager.

Ms. Nadia Tian, Co-founder and Co-CEO of Bridge Point Capital commented: “Grand Height’s profound resources and deep network in Asia and BPC’s expertise in the cross-border healthcare investment space is no doubt a perfect combination. Through this strategic partnership, we’re all excited to bring people in Asia the best cutting-edge healthcare technologies and products that never showed up in the past.”

The cooperation between the two firms started early this year, and officially formed strategic coorperations in May. BPC and GDHT Capital are working closely to jointly operate and manage several USD and RMB venture capital funds. The investment areas include Ophthalmology, Cardiovascular, Cancer Diagnostics and other subsectors in the healthcare space with high foreseeable growth potential in the two largest healthcare markets in the world.

A parallel fund structure is designed to make sure western companies and technologies are able to commercialize in Asia smoothly. The USD funds will invest in the parent companies in advance, and the RMB funds will then invest in these portfolio companies’ Asian subsidiaries to help them expand footprints in the region.

Mr. Bing Wen, president of GDHT Capital also commented: “Beijing Grand Height is proud to engage in such a relationship with Bridge Point Capital. We’ve seen huge growth momentum in the healthcare field, and we believe the two firm’s expertise in both healthcare and cross-border transactions will help our investors to locate more industry-leading healthcare deals that will thrive in both markets.”

About Bridge Point Capital:

Bridge Point Capital is a private equity firm based in New York, with a focus on U.S-Asia cross-border investments. We specialize in investing in disruptive mid- to late-stage healthcare companies that can benefit from penetrating the vast, yet unexplored Asian healthcare market. We aim to leverage our expertise in both healthcare and capital markets, to establish a lucrative investment platform for our investors.